ES
Estrella Immunopharma, Inc.
ESLA · NASDAQ
$0.69 -0.29% (-$0.00)
1M -13.23%
Market Cap $29.5M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
-
N/A EV/EBITDA N/A
P/S N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
57 /100
Average ROA 548.74%
Asset turnover 0.00x
ROIC 131.75%
Debt
0 /100
High Current ratio 0.20x
Int. coverage N/A
Net debt/EBITDA N/A
Stability
79 /100
Stable EPS volatility 11.03%
Profitable years 0
Beta 0.89x
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na ESLA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Cheng Liu
Employees
3
Headquarters
EmeryVille
Nadcházející události
02 PRO
Earnings
Upcoming earnings report